Related Experiment Video
Updated: Jul 21, 2026
09:35
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Infant and adolescent hepatitis B immunization up to 1999: a global overview
Vaccine
|January 4, 2001
Summary
Global hepatitis B immunization programs vary by region, with high coverage in endemic areas but challenges in vaccine affordability. Universal strategies reduce disease, yet most infants remain unvaccinated, necessitating improved delivery and financing.
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Vaccinology
Background:
- Hepatitis B virus (HBV) infection poses a significant global health burden, particularly in endemic regions.
- Infant and adolescent immunization are critical strategies for controlling HBV transmission and long-term sequelae.
- Understanding global immunization program patterns is essential for targeted public health interventions.
Purpose of the Study:
- To provide a comprehensive global overview of hepatitis B infant and adolescent immunization programs.
- To analyze factors influencing the implementation and coverage of these programs worldwide.
- To identify challenges and propose strategies for increasing global hepatitis B vaccination rates.
Main Methods:
- Analysis of reported universal infant or adolescent immunization programs (n=108) and national infant coverage rates (n=87).
- Correlation of program data with hepatitis B endemicity, national prosperity, policy emphasis, and immunization program strength.
- Geographical mapping and comparative analysis of vaccination strategies across different global regions.
Main Results:
- Hepatitis B immunization coverage varies globally, generally correlating with regional endemicity, economic status, and policy focus.
- High coverage (65-100%) is observed in many East/Southeast Asian, Pacific, Middle Eastern, and some European countries.
- Despite proven effectiveness, many countries face challenges affording the vaccine, leading to low global infant immunization rates.
Conclusions:
- Universal hepatitis B immunization programs have successfully reduced disease incidence and prevalence, demonstrating cost-effectiveness.
- Significant barriers remain, including vaccine affordability and logistical challenges in reaching all infants globally.
- Future strategies may involve heat-stable vaccines, innovative financing, and multivalent vaccines to improve global coverage and reduce hepatitis B burden.
More Related Videos
Related Concept Videos
01:51Vaccinations
Overview
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...